Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) just unveiled an announcement.
Fuso Pharmaceutical Industries, Ltd. announced changes in its executive officer positions, effective September 1, 2025, following a Board of Directors meeting. These personnel changes involve reassignments within the company’s production division, impacting the management of its Ibaraki and Okayama factories, which may influence operational efficiencies and strategic positioning in the industry.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market and is led by President and Representative Director Mikio Toda.
Average Trading Volume: 17,159
Technical Sentiment Signal: Buy
Current Market Cap: Yen19.39B
See more data about 4538 stock on TipRanks’ Stock Analysis page.

